| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0001 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |